HDL cholesterol predicts coronary heart disease mortality in older persons

Article Abstract:

Low levels of high density lipoprotein cholesterol (HDL-C) appear to increase the risk of death from coronary heart disease (CHD) in older people. Between 1987 and 1989, researchers interviewed and took blood samples from 3,904 people who were at least 71 years of age. After a median follow-up period of 4.4 years, people with low HDL-C levels were 2.5 times more likely to die from CHD than people with higher HDL-C levels, independent of other CHD risk factors. Compared to their same gender counterparts with higher HDL-C levels, men with low HDL-C were nearly five times more likely to die of CHD and women with low HDL-C were twice as likely to die of CHD. Low HDL-C increased the risk of chest pain, heart attacks, or sudden death among men and women with no history of a heart attack or recent CHD hospitalization. High total cholesterol levels were associated with an increased risk of death from CHD in women, but not in men.

Health aspects, Aged, Elderly, Coronary heart disease, Cholesterol, HDL, HDL cholesterol lipoproteins, Blood cholesterol

---

Effect of estrogen therapy on gallbladder disease

Article Abstract:

A study conducted to determine the effect of estrogen therapy in healthy postmenopausal women on gallbladder disease outcomes is reported. The results suggest an increase in risk of biliary tract disease among postmenopausal women using estrogen therapy.

Influence, Drug therapy, Gallbladder diseases, Postmenopausal women, Estrogen, Estrogen antagonists

---

Similar abstracts:

• Abstracts: AIDS mortality among Puerto Ricans and other Hispanics in New York City, 1981-1987. National AIDS incidence trends and the extent of zidovudine therapy in selected demographic and transmission groups
• Abstracts: Prevention of excess mortality in refugee and displaced populations in developing countries. Refugees and displaced persons: war, hunger and public health
• Abstracts: Predictors of morbidity and mortality in neonates with herpes simplex virus infections. A controlled trial comparing vidarabine with acyclovir in neonatal herpes simplex virus infection
• Abstracts: Progress in pathogenesis and management of clinical intraamniotic infection. Evidence relating bacteria vaginosis to intraamniotic infection
• Abstracts: Hold the line - an opportunity revisited. An oversupply in the offing? Back to the future

This website is not affiliated with document authors or copyright owners. This page is provided for informational purposes only. Unintentional errors are possible.